Detalhe da pesquisa
1.
Factors Influencing Admission Decisions in Skilled Nursing Facilities: Retrospective Quantitative Study.
J Med Internet Res
; 25: e43518, 2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195755
2.
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
N Engl J Med
; 378(4): 354-369, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365309
3.
Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers.
BMC Nephrol
; 22(1): 204, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074247
4.
Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered With Human Immunodeficiency Virus Antiretrovirals.
J Infect Dis
; 221(2): 223-231, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504702
5.
Glecaprevir/pibrentasvir for 8â¯weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial.
J Hepatol
; 72(3): 441-449, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682879
6.
Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease.
Clin Infect Dis
; 69(10): 1657-1664, 2019 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923816
7.
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
J Viral Hepat
; 26(3): 337-349, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30421537
8.
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.
Hepatology
; 67(2): 514-523, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28926120
9.
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis.
J Hepatol
; 69(2): 293-300, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551706
10.
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.
Clin Gastroenterol Hepatol
; 16(3): 417-426, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28951228
11.
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.
J Hepatol
; 67(2): 263-271, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412293
12.
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
Gastroenterology
; 151(4): 651-659.e1, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27456384
13.
B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.
Blood
; 123(10): 1512-5, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24449209
14.
Characterizing complex and competing drug-drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine.
Clin Transl Sci
; 16(4): 593-605, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597378
15.
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19.
Pharmacol Res Perspect
; 11(1): e01036, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36537346
16.
Biomarkers for the clinical development of antiviral therapies.
Cytometry B Clin Cytom
; 100(1): 19-32, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34542933
17.
Description of antibiotic use variability among US nursing homes using electronic health record data.
Antimicrob Steward Healthc Epidemiol
; 1(1): e58, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-36168476
18.
Electrocardiographic determination of culprit lesion site in patients with acute coronary events.
J Electrocardiol
; 42(1): 46-51, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18976776
19.
Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies.
Drug Alcohol Depend
; 194: 487-494, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529905
20.
Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release.
mBio
; 9(2)2018 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29535204